FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
+9.15%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$196M
AUM Growth
+$196M
(+11%)
Cap. Flow
+$9.87M
Cap. Flow
% of AUM
5.04%
Top 10 Holdings %
Top 10 Hldgs %
46.87%
Holding
69
New
3
Increased
33
Reduced
3
Closed
7
Top Buys
| 1 |
Insmed
INSM
|
$4.37M |
| 2 |
TEAR
TearLab Corporation
TEAR
|
$3.97M |
| 3 |
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
|
$2.22M |
| 4 |
Verastem
VSTM
|
$2.12M |
| 5 |
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
|
$1.92M |
Top Sells
| 1 |
Vanda Pharmaceuticals
VNDA
|
$3.29M |
| 2 |
SPNC
Spectranetics Corp
SPNC
|
$2.94M |
| 3 |
ARRY
Array Biopharma Inc
ARRY
|
$2.61M |
| 4 |
Align Technology
ALGN
|
$2.05M |
| 5 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
$2M |
Sector Composition
| 1 | Healthcare | 88.63% |
| 2 | Consumer Staples | 0.8% |
| 3 | Financials | 0.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
AtriCure
ATRC
$1.84B
| $14.5M | 7.38% | 705,570 +69,400 | +11% | +$1.42M |
|
2
NeoGenomics
NEO
$1.13B
| $13.8M | 7.06% | 2,962,024 +278,934 | +10% | +$1.3M |
|
|
AKRX
3
DELISTED
Akorn, Inc.
AKRX
| $12.1M | 6.2% | 255,711 +23,019 | +10% | +$1.09M |
|
4
Harvard Bioscience
HBIO
$22M
| $9.09M | 4.64% | 1,562,504 +149,785 | +11% | +$872K |
|
|
SPNC
5
DELISTED
Spectranetics Corp
SPNC
| $7.91M | 4.04% | 227,617 -84,641 | -27% | -$2.94M |
|
|
SRGA
6
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $7.72M | 3.94% | 1,562,664 +148,854 | +11% | +$735K |
|
|
NXTM
7
DELISTED
NxStage Medical Inc.
NXTM
| $7.12M | 3.64% | 411,717 +38,553 | +10% | +$667K |
|
8
Ligand Pharmaceuticals
LGND
$3.15B
| $7.05M | 3.6% | 91,384 +9,432 | +12% | +$727K |
|
|
TLGT
9
DELISTED
Teligent, Inc
TLGT
| $6.58M | 3.36% | 806,255 +71,795 | +10% | +$586K |
|
|
TEAR
10
DELISTED
TearLab Corporation
TEAR
| $5.87M | 3% | 2,950,478 +1,997,267 | +210% | +$3.97M |
|
|
OXFD
11
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $5.78M | 2.95% | 410,150 +136,677 | +50% | +$1.92M |
|
|
ARRY
12
DELISTED
Array Biopharma Inc
ARRY
| $5.72M | 2.92% | 775,726 -353,834 | -31% | -$2.61M |
|
|
ELGX
13
DELISTED
Endologix Inc
ELGX
| $4.73M | 2.42% | 277,264 +26,895 | +11% | +$459K |
|
14
Celldex Therapeutics
CLDX
$1.47B
| $4.71M | 2.41% | 169,145 +15,528 | +10% | +$433K |
|
15
Omnicell
OMCL
$1.5B
| $4.7M | 2.4% | 133,858 +13,373 | +11% | +$469K |
|
|
16
Insmed
INSM
$28.8B
| $4.37M | 2.23% | +210,066 | New | +$4.37M |
|
17
Bio-Techne
TECH
$8.5B
| $4.32M | 2.2% | 43,036 +3,793 | +10% | +$380K |
|
18
QuidelOrtho
QDEL
$1.95B
| $4.25M | 2.17% | 157,665 +14,573 | +10% | +$393K |
|
|
NVDQ
19
DELISTED
Novadaq Technologies Inc.
NVDQ
| $3.97M | 2.03% | 244,238 +21,339 | +10% | +$347K |
|
|
ENZ
20
DELISTED
Enzo Biochem, Inc.
ENZ
| $3.91M | 2% | 1,324,322 +110,421 | +9% | +$326K |
|
21
AngioDynamics
ANGO
$417M
| $3.84M | 1.96% | 215,783 +21,271 | +11% | +$378K |
|
22
Standard BioTools
LAB
$481M
| $3.77M | 1.92% | 89,492 +8,879 | +11% | +$374K |
|
|
STRM
23
DELISTED
Streamline Health Solutions
STRM
| $3.54M | 1.81% | 996,235 +92,503 | +10% | +$328K |
|
|
LCI
24
DELISTED
Lannett Company, Inc.
LCI
| $3.37M | 1.72% | 49,769 +4,004 | +9% | +$271K |
|
25
Veracyte
VCYT
$2.39B
| $3.2M | 1.64% | 440,003 +46,077 | +12% | +$335K |
|